New guideline: Barrett's esophagus precedes esophageal cancer, but not all patients need abnormal cell removal
Patients with Barrett's esophagus (dysplasia or early cancer) should be treated and monitored by expert endoscopists and ...
Medscape4d
Radiofrequency Ablation as a Treatment of Dysplastic Barrett's Esophagus
The BCBSA Technology Evaluation Center (TEC) has conducted an assessment of radiofrequency ablation for the treatment of low grade dysplasia in Barrett's Esophagus inNovember 2010 (it was posted ...
Johns Hopkins Medicine17d
Researchers Develop Biomarker Algorithm for Barrett’s Esophagus and Esophageal Cancer
“Our study used a methodically rigorous process to identify biomarkers, and we believe this represents the first study to ...
Medscape16d
Barrett's Esophagus: Can Biomarkers Predict Progression to Malignancy?
Gastroenterology 122(2), 588-590 (2002). Haggitt RC. Barrett's esophagus, dysplasia and adenocarcinoma. Hum. Pathol. 25(2), 982-993 (1994). Sharma P, Marcon N, Wani S et al. Non-biopsy detection ...
Nature7y
Multispectral light scattering endoscopic imaging of esophageal precancer
The main stumbling block in visualizing dysplasia in BE is the need for ... The system scans the entire Barrett's esophagus segment in minutes, providing the endoscopist with real time information ...
Business Wire1mon
Castle Biosciences Announces New York State Department of Health Approval of Its TissueCypher® Barrett’s Esophagus Test
FRIENDSWOOD, Texas--(BUSINESS WIRE)--Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it has received ...
Morningstar17d
WATS3D Solution: Barretts and Esophageal Cancer Early Detection Test Reaches 73 Million Covered Lives with New Payer Contracts
A recent 2024 study of 23,933 patients published in the American Journal of Gastroenterology noted that WATS3D diagnosed an additional 20% of Barrett's esophagus cases across all EGDs performed ...
Medical Xpress17d
Biomarker algorithm for Barrett's esophagus and esophageal cancer developed
Extending the ability to identify healthy control patients versus patients with Barrett's esophagus and high-grade dysplasia or esophageal cancer combined, the AUC was 0.86, which Meltzer says is ...
Yahoo Finance1mon
Castle Biosciences Announces New York State Department of Health Approval of Its TissueCypher® Barrett’s Esophagus Test
TissueCypher is the first AI-driven precision medicine test designed to predict a patient’s individual risk of progression from Barrett’s esophagus (BE) to esophageal cancer. "We are proud of ...